BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed exclusive agreements with three new dermatology focused distributors to market ELEVESS in Mexico, Chile, Peru and South Korea. ELEVESS is an injectable filler that reduces the appearance of lines and wrinkles on the face, and was the first HA-based dermal filler approved by the U.S. Food and Drug Administration to incorporate the anesthetic lidocaine to improve patient comfort. The agreements provide exclusive distribution rights for ELEVESS in each of these growing markets.
